posted on 2021-11-03, 20:33authored byGuo-Chong Chen, Rhonda Arthur, Victor Kamensky, Jin Choul Chai, Bing Yu, Aladdin H. Shadyab, Matthew Allison, Yangbo Sun, Nazmus Saquib, Robert A Wild, Wei Bao, Andrew J. Dannenberg, Thomas E. Rohan, Robert C. Kaplan, Sylvia Wassertheil-Smoller, Qibin Qi
<b>OBJECTIVE </b>
<p>To assess
the relationship between body fat distribution and incident lower-extremity arterial disease (LEAD). </p>
<p><b>RESEARCH
DESIGN AND METHODS </b></p>
<p>We
included 155,925 postmenopausal women with anthropometric measures from the
Women’s Health Initiative who had no known LEAD at recruitment. A subset of 10,894 participants had body composition data
quantified by dual energy X-ray
absorptiometry (DXA). Incident cases of
symptomatic LEAD were ascertained and adjudicated via medical
record review.</p>
<p><b>RESULTS </b></p>
<p>We identified 1152 incident LEAD cases during a
median 18.8 years follow-up. After multivariable adjustment and mutual
adjustment, waist and hip
circumference was positively and inversely associated with risk of LEAD, respectively (both P-trend values
<0.0001). In a subset (n = 22,561) where various cardiometabolic biomarkers
were quantified, a similar positive association of waist circumference with
risk of LEAD was eliminated
after adjustment for diabetes and HOMA-IR (P-trend = 0.89), whereas hip
circumference remained inversely associated with the risk after adjustment for major
cardiometabolic traits (P-trend = 0.0031). In the DXA subset, higher trunk fat (P-trend = 0.0081)
and higher leg fat (P-trend <0.0001) was associated with higher and lower
risk of LEAD, respectively. Further
adjustment for diabetes, dyslipidemia, and blood pressure diminished the
association for trunk fat (P-trend = 0.49), yet the inverse association for leg
fat persisted (P-trend = 0.0082).</p>
<p><b>CONCLUSIONS</b></p>
<p>Among US
postmenopausal women, a positive association of upper-body fat with risk of LEAD appeared to be attributable to
traditional risk factors especially insulin resistance. Lower-body fat was
inversely associated with risk of LEAD
beyond known risk factors. </p>
Funding
The WHI program is funded by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C. Dr. Qi is supported by the NHLBI (K01HL129892, R01HL060712, and R01HL140976) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK119268 and R01DK120870), and Dr. Kaplan is supported by the NHLBI (R01-HL146132-01).